Study Data from National Cancer Centre Singapore Update Knowledge of Kinase Inhibitors (Real-world Outcomes of Pemetrexed-platinum Chemotherapy Plus Osimertinib After Progression On First-line Osimertinib In Advanced Egfr-mutated Nsclc)

Press/Media

Period25 Jul 2024

Media coverage

1

Media coverage

  • TitleStudy Data from National Cancer Centre Singapore Update Knowledge of Kinase Inhibitors (Real-world Outcomes of Pemetrexed-platinum Chemotherapy Plus Osimertinib After Progression On First-line Osimertinib In Advanced Egfr-mutated Nsclc)
    Media name/outletEducation Daily Report
    Country/TerritoryUnited States
    Date25/07/24
    PersonsKA HOU CHAN
View all 1
View less